[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Associazione Italiana per lo Studio del Pancreas\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":126},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,44,66,96],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100495586",false,"NCT05733130","Italian Registry Chronic Pancreatitis","Registro Italiano Pancreatite Cronica","ITARECIPE","Inclusion Criteria:\n\n* Age \\>\u002F= 12 years;\n* Diagnosis \"definite\" or \"probable\" according to the \"M-ANNHEIM\" criteria;\n* First evidence of diagnosis within 12 months of enrolment.\n\nExclusion Criteria:\n\n* Age \\\u003C 12 years;\n* History of known disease with certainty for \\> 12 months.","ALL","12 Years",{"count":19,"type":20},1500,"ESTIMATED","5 Years","OBSERVATIONAL","ITARECIPE is a multicenter national registry designed to study the diagnosis and evolution of Chronic Pancreatitis",[25],"Chronic Pancreatitis",[27,28,29,30],"chronic pancreatitis","surveillance chronic pancreatitis","chronic pancreatitis diagnosis","chronic pancreatitis therapy","RECRUITING","2024-07-10",{"date":34,"type":35},"2024-07-11","ACTUAL",{"date":37,"type":35},"2022-10-10",{"date":39,"type":20},"2027-12-31",{"name":41,"class":42},"Associazione Italiana per lo Studio del Pancreas","OTHER",1,{"id":45,"slug":4,"hasResults":10,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":10,"sex":16,"minAge":51,"maxAge":4,"enrollmentInfo":52,"targetDuration":54,"studyType":22,"phases":4,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":43},"100545396","NCT06381362","Italian Registry of Minimally Invasive Pancreatic Surgery","Italian Registry of Minimally Invasive Pancreatic Surgery (IGOMIPS)","IGOMIPS","Inclusion Criteria:\n\n* Age \\> 18 years;\n* Underwent minimally invasive pancreatic surgery\n\nExclusion Criteria:\n\n* Pregnant woman\n* Minor or unable to give informed consent","18 Years",{"count":53,"type":20},2300,"3 Months","Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes",[57],"Pancreatic Surgery","2024-04-22",{"date":60,"type":35},"2024-04-24",{"date":62,"type":35},"2019-02-28",{"date":64,"type":20},"2029-02-28",{"name":41,"class":42},{"id":67,"slug":4,"hasResults":10,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":10,"sex":16,"minAge":51,"maxAge":73,"enrollmentInfo":74,"targetDuration":4,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":43},"100494962","NCT05724992","Familial Pancreatic Cancer PROPHilation Program in Italy","Standardised Genetic Profiling of Subjects Belonging to the Italian Multicenter Registry of Prospective Surveillance of Subjects at Genetic Risk of Pancreatic Cancer","PROPH-ITA","Inclusion Criteria:\n\n* Being enrolled on the IRFARPC registry\n* Having familiarity for pancreatic cancer (according to the IRFARPC criteria, Capurso et al. Dig Liv Dis, 2020)\n* Willingness to participate in saliva-swab-based genetic testing\n\nExclusion Criteria:\n\n\\- Already known genetic mutation","80 Years",{"count":75,"type":20},3000,"INTERVENTIONAL",[78],"NA","The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only.\n\nParticipants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test.\n\nUp to 3,000 participants will be enrolled in this study.",[81],"Candidates for Hereditary Pancreatic Cancer Testing",[83,84,85,86,87],"Pancreatic Cancer","Pancreatic Cancer familiarity","Genetic profiling","Genetic predisposition","Pancreatic Cancer surveillance","2023-02-13",{"date":90,"type":35},"2023-02-15",{"date":92,"type":35},"2022-12-20",{"date":94,"type":20},"2028-12-20",{"name":41,"class":42},{"id":97,"slug":4,"hasResults":10,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":101,"eligibilityCriteria":102,"healthyVolunteers":10,"sex":16,"minAge":51,"maxAge":73,"enrollmentInfo":103,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":105,"conditions":106,"keywords":114,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":5},"100369811","NCT04095195","Registry of Subjects at Risk of Pancreatic Cancer","Italian Registry of Families At Risk of Pancreatic Cancer","IRFARPC","Inclusion Criteria to enter the registry:\n\n* individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree\n* subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer\n* subjects suffering from FAMMM Syndrome\n* subjects suffering from Peutz-Jeghers Syndrome\n* subjects suffering from PRSS-1- or CFTR- or SPINK-1- related pancreatitis\n* subjects suffering from Lynch syndrome with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer\n\nInclusion criteria to join the \"radiologic follow-up\":\n\n* 45 years or 10 years younger than the youngest index case of pancreatic cancer in the family for familial cases\n* 40 years or 5 years younger than the youngest index case of pancreatic cancer for subjects suffering from hereditary\u002Fgenetic pancreatitis, Lynch syndrome, or carrying a known BRCA 1\u002F2, PALB2, p16 genetic mutation with familiarity for pancreatic cancer\n* 30 years for subjects suffering from FAMMM, Peutz-Jeghers syndrome\n\nExclusion Criteria:\n\n\\- pregnancy",{"count":104,"type":20},1000,"IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.",[107,108,109,110,111,112,113],"Familial Pancreatic Cancer","BRCA1 Mutation","BRCA2 Mutation","Lynch Syndrome","FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome","Hereditary Pancreatitis","Peutz-Jeghers Syndrome",[107,115,110,116,117],"BRCA Mutation","Screening pancreatic cancer","Surveillance pancreatic cancer","2023-01-12",{"date":120,"type":35},"2023-01-13",{"date":122,"type":35},"2019-08-20",{"date":124,"type":20},"2045-09-20",{"name":41,"class":42},""]